Free CME from PeerView


Nephrology CME

Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
September 24, 2021
Credits: 0.5 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
September 20, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
September 15, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
September 09, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
September 07, 2021
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Redrawing the Algorithm in Gastric and GEJ Cancers: Treatment Planning and Sequencing in the Era of Immunotherapy
August 23, 2021
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Credits: 1.0 NCPD
Medical Learning Institute, Inc.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
August 18, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
July 09, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
July 07, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
July 07, 2021
Credits: 1.5 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
July 06, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
July 05, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
July 05, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
July 05, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer
July 02, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Pushing Therapeutic Boundaries in CLL: The Convergence of Targeted Therapy, Novel Combinations, and Precision Medicine in Patient Care
July 02, 2021
Nicola Gökbuget, MD
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Achieving Therapeutic Innovation in ALL: Insights on Modern Asparaginase Compounds in Pediatric, AYA, and Adult Patients
June 30, 2021
Credits: 1.5 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices
June 29, 2021
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
June 23, 2021
PVI, PeerView Institute for Medical Education
New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease
June 21, 2021
Medical Learning Institute, Inc.
Leading the Way in Multiple Myeloma: Nurse Perspectives on Recent Developments With Novel Therapeutics
June 21, 2021
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
June 08, 2021

Pages